Dixon Mitchell Investment Counsel’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-130	Closed	-$18.6K	–	137
2024 Q2	$18.6K	Sell	130 -70	-35%	-$9.99K	﹤0.01%	92
2024 Q1	$25.9K	Buy	+200	New	+$25.9K	﹤0.01%	103